Compare Aevo (AEVO) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aevo vs Enzyme — how do they compare? Aevo trades at Rp327.38 (market cap Rp300,45M, Rp54,15M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Aevo is far larger — about 2.2× Enzyme's market cap, and Aevo's supply is capped (917,2M / 1B AEVO (92%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 87 Days and Enzyme for 28 Days on average.
| AEVO | MLN | |
|---|---|---|
Market Cap | Rp300,45M | Rp134,13M |
Volume (24h) | Rp54,15M | Rp104,56M |
Circulating Supply | 917,2M / 1B AEVO (92%) | 3,3M MLN |
Typical Hold Time | 87 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aevo is currently trading at Rp326.46 with a market cap of Rp301.12 million, showing a bearish technical signal as moving averages indicate selling pressure. The token trades near key support at Rp325, with neutral oscillators suggesting consolidation. No major protocol updates or ecosystem developments were noted recently, keeping fundamental drivers subdued.
Overall outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from support levels, while risks involve high volatility and limited market depth. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Aevo
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
